The Neuromuscular Disease Network for Canada

funder-logos_nmd4c

Expert Patient Capacity Building Update

Canadians with NMD, their families, and advocates are increasingly asked to take an active role in research initiatives. Research and advocacy training empowers patients and ensures they have the confidence and knowledge needed to share their expertise to guide discussions and inform decisions regarding health care, research, and therapy development for policy makers, industry, and scientists.

 

The NMD4C is involved in several activities under the provision of our Training and Education initiatives, including the establishment of expert patient capacity building (EPCB) resources for Canadian NMD patients. The EPCB team’s work involves the promotion of patient engagement in all aspects of NMD, and the development of easy-to-use and accessible Canadian NMD training modules and resources for both patients and researchers to support patient-oriented neuromuscular research in Canada.

 

To facilitate the network’s EPCB activities, the NMD4C is excited to announce the hiring of Patricia Mortenson, who has joined this team as project coordinator.

Read Patricia’s full bio here!

 

To assist in the development of modules to train patients and researchers to partner effectively, the EPCB team is reviewing the Canadian research landscape to find current resources and programs. Throughout all EPCB work, the team will utilize the Strategy for Patient-Oriented Research (SPOR) Patient Engagement Framework developed by CIHR. This framework allows patients to provide knowledge and input drawn from their unique experience gained through living with a condition or illness, and their first-hand experience in navigating treatments and the Canadian health care system.

The NMD4C encourages you to share any relevant expert patient capacity building resources that you know of with our team!

If you are a researcher who has experience in working with expert patients, we would also love to hear from you!

 

Please complete this short 5-minute survey here!

image from https://fshoq.com/

Read next...

Fellowship Map_news

Clinical Research Curriculum Development Working Group Update

The NMD4C is committed to educating the next generation of NMD stakeholders, and endeavors to optimize the training of neuromuscular clinicians in Canada through standardization of a fellowship curriculum, preparing an application for an Area of Focused Competency (AFC) by the Royal College of Physicians and Surgeons of Canada in the field of Neuromuscular Medicine, and holding quarterly CPD-accredited NM Mystery Case Rounds.

medicine capsules spilling out of a jar

Response to the Federal Government on Building a National Strategy for High-Cost Drugs for Rare Diseases

The Neuromuscular Disease Network for Canada (NMD4C) in partnership with Muscular Dystrophy Canada (MDC)  and The Foundation for Gene & Cell Therapy (Jesse’s Journey) are pleased to provide the following summary of our recommendations for consideration into the National Strategy for Rare Diseases.

MDC_ImagineAccredxcf

MDC Press Release | Muscular Dystrophy Canada Awarded Imagine Canada Accreditation

This prestigious accreditation is an official complement to the extraordinary scope of work MDC does to support the neuromuscular community, influence positive change with advocacy and fund basic and translational research in the field of NMD.

logos-treat-nmd-logo

NMD4C steering committee member Dr. Jim Dowling appointed Chair of the executive committee of TREAT-NMD

The NMD4C would like to congratulate our Steering Committee member Dr. Jim Dowling on his appointment as Chair of the executive committee of TREAT-NMD!

ENMC logo topkwaliteit

Launch of ENMC Mid-Career Mentoring Programme

Building from the success of the ENMC Early-Career Programme, the ENMC is proud to launch a new and ambitious Mid-Career Mentoring Programme.

image001

Rare Disease Day 2021 Recap

Observed annually on the last day of February, Rare Disease Day seeks to raise awareness among the general public, as well as policymakers, public authorities, industry representatives, scientists, and health professionals.   Due to the COVID-19 pandemic, activities this year were mainly virtual. But that did not stop patients, caregivers, researchers, clinicians, advocates and patient…